Todd Burus’s research while affiliated with University of Kentucky and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (18)


Cancer InFocus impact on cancer centers model. Adapted from the EFQM.¹⁴
Catchment areas of Cancer InFocus adopters. Highlighted regions represent the combined catchment areas of all cancer centers and state cancer registries with licensing agreements to use Cancer InFocus as of October 31, 2024.
Cancer InFocus User Impact survey results. Respondents answered the following questions about their experiences with CIF compared to their previous methods: (A) time spent gathering data with CIF, (B) effort spent gathering data with CIF, (C) amount of data gathered with CIF, (D) time spent disseminating data with CIF, (E) effort spent disseminating data with CIF, and (F) financial cost of disseminating data with CIF. CIF indicates Cancer InFocus.
Measuring the impact of a catchment area surveillance tool on cancer center adopters
  • Article
  • Full-text available

January 2025

·

3 Reads

Todd Burus

·

Caree R. McAfee

·

Natalie P. Wilhite

·

Pamela C. Hull

Background The University of Kentucky Markey Cancer Center developed the data gathering and visualization platform Cancer InFocus (CIF) as a solution for cancer center catchment area surveillance. CIF was released in June 2022 and made available for use to other institutions through a no‐cost licensing agreement. The purpose of this study was to evaluate the impact CIF has had on cancer centers since its release. Methods The authors adapted an existing management evaluation framework to assess the impact of CIF across three spheres—idea dissemination, product engagement, and adopter satisfaction. This assessment included an online survey administered between the dates of September 18, 2023 and June 22, 2024 among 28 individuals at 13 CIF adopting institutions. Results As of October 2024, the ideas and approaches of CIF had been disseminated with national audiences 13 times and featured in one peer‐reviewed publication. Thirty‐five institutions, including 26 National Cancer Institute–Designated Cancer Centers, had engaged in licensing CIF. In a user satisfaction survey among adopting institutions, a majority of individuals indicated they were gathering more data (91.7%) and requiring less effort to disseminate data (72.0%) using CIF than under their previous methods. Conclusions CIF has demonstrated a broad and positive impact on cancer center catchment area surveillance in the 2 years since its release. CIF represents a high value, low‐cost option for cancer centers wanting to build a cancer surveillance dashboard. The framework used for evaluating CIF's impact can be adapted to assess the impact of other open‐source software built and distributed by cancer centers.

Download




State‐level lung adenocarcinoma incidence rates and average annual percentage change (AAPC) by sex, 2005–2019. (A) Female incidence rates, 2005, (B) female incidence rates, 2019, (C) females AAPCs, 2005–2019, (D) male incidence rates, 2005, (E) male incidence rates, 2019, (F) males AAPCs, 2005–2019. [Color figure can be viewed at wileyonlinelibrary.com]
State‐level lung adenocarcinoma incidence rate ratio (IRR) for 2015–2019 versus 2005–2009 by sex and age at diagnosis. (A) Female, under 55 years old, (B) male, under 55 years old, (C) female, 55 years or older, (D) male, 55 years or older. [Color figure can be viewed at wileyonlinelibrary.com]
Annual lung adenocarcinoma incidence rates and trends by stage and sex, 2005–2019. (A) Early stage at diagnosis, (B) late stage at diagnosis. Trends measured using Joinpoint regression with annual percentage change (APC) of segments displayed.¹⁹ (*) indicates statistically significant APC for segment (p <.05). [Color figure can be viewed at wileyonlinelibrary.com]
State‐level lung adenocarcinoma incidence rate ratio (IRR) for 2015–2019 versus 2005–2009 by sex and stage at diagnosis. (A) Female, early‐stage, (B) male, early‐stage, (C) female, late‐stage, (D) male, late‐stage. Stage at diagnosis was determined using the Merged Summary Stage variable.¹⁶ Localized cases were classified as “early‐stage.” Regional and distant cases were classified as “late‐stage.” [Color figure can be viewed at wileyonlinelibrary.com]
Association between sex‐specific lung adenocarcinoma incidence rate ratio (IRR) for 2015–2019 versus 2005–2009 and average lung cancer screening recommendations adherence for 2016–2018. (A) Female, (B) male. Correlation measured on the basis of Spearman's rank correlation coefficient. [Color figure can be viewed at wileyonlinelibrary.com]
Sex‐based differences in histologic lung cancer incidence trends in the United States, 2005–2019

November 2024

·

10 Reads

Decreases in lung cancer incidence in the United States (US) have paralleled decreasing smoking prevalence for several decades; however, recent data has revealed slower declines among females than males. Sex‐based differences in histologic lung cancer—and specifically adenocarcinoma—for all 50 US states and the District of Columbia have never been investigated. Using population‐based cancer registry data from the US Cancer Statistics, we examined age‐adjusted histologic lung cancer incidence rates and trends by sex and state of residence at diagnosis. We compared state‐level adenocarcinoma incidence to lung cancer screening (LCS) adherence and smoking prevalence estimates. Average annual percentage change (AAPC) and incidence rate ratios (IRR) were used to assess changes over time. Nationally, females experienced faster increases in adenocarcinoma incidence than males (1.75%/year vs. 0.35%/year), and slower decreases in incidence of squamous cell (−0.06%/year vs. −1.58%/year) and small cell carcinoma (−2.06%/year vs. −3.19%/year). Adenocarcinoma incidence increased significantly (AAPC>0) in 41 states among females compared to 10 among males. Significant adenocarcinoma increases in individuals under age 55 (IRR >1) occurred among females in six states (four in the southeastern US) and none among males. State‐level LCS adherence was significantly associated with adenocarcinoma incidence among females (r = 0.39; p<.01) but not males, though screening cannot account for increases among females under age 55. Our results highlight sex‐based differences in histologic lung cancer incidence trends, with specific concern for increases in adenocarcinoma in the southeastern US. Further research is needed into appropriate LCS eligibility criteria and the risk factors driving sex‐based disparities.


Tracking Community Outreach and Engagement Activities among National Cancer Institute-Designated Cancer Centers

September 2024

·

3 Reads

JNCI Journal of the National Cancer Institute

The National Cancer Institute's (NCI) Cancer Center Support Grant mandates that NCI-Designated Cancer Centers establish a Community Outreach and Engagement (COE) component to help direct efforts at reducing cancer burden within their catchment areas. Despite the critical role of COE offices, little is known about how they track and evaluate outreach activities and outcomes. We gathered information on current practices from representatives of 40 out of 65 COE offices using an online survey. While nearly all responding centers (97.5%) tracked COE activities, no consensus existed on resources used and satisfaction with current solutions was mixed (51.0% not satisfied). Respondents expressed need for a centralized, standardized, and comprehensive tracking solution to capture outreach events and external partnerships, automate report generation, and ensure alignment with COE aims. This study highlights challenges COE offices face with resource limitations and a heterogeneity of activities to track, and the need for a standard evaluation framework.


COVID-19 and Rates of Cancer Diagnosis in the US

September 2024

·

3 Reads

·

3 Citations

JAMA Network Open

Importance US cancer diagnoses were substantially lower than expected during the COVID-19 pandemic in 2020. A national study on the extent to which rates recovered in 2021 has not yet been conducted. Objective To examine observed vs expected cancer rate trends for January 2020 to December 2021. Design, Setting, and Participants This cross-sectional, population-based study of cancer incidence trends used the Surveillance, Epidemiology, and End Results 22 (SEER-22) Registries Database, which covers 47.9% of the US population. Included individuals were those with an invasive cancer diagnosis reported to registries included in SEER-22 between January 1, 2000, and December 31, 2021. Exposures Age, sex, race and ethnicity, urbanicity, and stage at diagnosis. Main Outcomes and Measures Expected cancer incidence rates were measured for the COVID-19 pandemic years of 2020 and 2021 from prepandemic trends using ensemble forecasting methods. Relative difference between observed and expected cancer incidence rates and numbers of potentially missed cases were measured. Results The SEER-22 registries reported 1 578 697 cancer cases in 2020 and 2021, including 798 765 among male individuals (50.6%) and 909 654 among persons aged 65 years or older (57.6%). Observed all-sites cancer incidence rates were lower than expected by 9.4% in 2020 (95% prediction interval [PI], 8.5%-10.5%), lower than expected by 2.7% in 2021 (95% PI, 1.4%-3.9%), and lower than expected by 6.0% across both years combined (95% PI, 5.1%-7.1%), resulting in 149 577 potentially undiagnosed cancer cases (95% PI, 126 059-176 970). Of the 4 screening-detected cancers, only female breast cancer showed significant recovery in 2021, exceeding expected rates by 2.5% (95% PI, 0.1%-4.8%), while significant reductions remained for lung cancer (9.1% lower than expected; 95% PI, 6.4%-13.2%) and cervical cancer (4.5% lower than expected; 95% PI, 0.4%-8.0%), particularly for early stage at diagnosis. Rates of all-sites cancer incidence returned to prepandemic trends in 2021 among female individuals, persons aged younger than 65 years, and persons of non-Hispanic Asian and Pacific Islander race and ethnicity. Conclusions and Relevance This population-based cross-sectional study of US cancer incidence trends found that rates of diagnosis improved in 2021 but continued to be lower than expected, adding to the existing deficit of diagnosed cases from 2020. Particular attention should be directed at strategies to immediately increase cancer screenings to make up lost ground.




Implementing Virtual Qualitative Data Collection in a Statewide Cancer Needs Assessment: Focus Group Study (Preprint)

June 2024

·

8 Reads

BACKGROUND Qualitative methods can provide a valuable complement to quantitative data in community health needs assessments to gain a deeper understanding of community perspectives on needs, inequities, and potential solutions. For needs assessments focusing on a large geographic area, it is challenging to collect qualitative data from a variety of different rural and urban contexts. In 2021, a steering committee of academic and community organizations in Kentucky (KY) was formed to drive a multi-method, statewide cancer needs assessment (CNA) to identify needs and future priorities for the state. OBJECTIVE This article reports on the virtual focus group component of the CNA. The objectives were to: 1) document existing community resources and perceived needs across the cancer care continuum and 2) explore the impacts of social determinants of health and the needs unique among populations that experience health disparities. METHODS We recruited adult KY residents who were not employed in health occupations to participate in 11 virtual 60-minute focus groups, with stratified sampling to include multiple target populations and geographic areas. We based our semi-structured discussion guide on the cancer care continuum domains and additionally focused on social determinants of health, health equity, and other factors affecting cancer diagnoses and outcomes. We conducted qualitative line-by-line analysis of the session recording transcripts to identify themes. RESULTS Participants (N=51) lived in 25 different counties, including 35% from rural communities, 14% from Appalachian KY, and 31% who self-identified as a racial or ethnic minority. We identified a variety of themes representing community-perceived needs and potential solutions across the cancer care continuum, including the need for the following: 1) novel approaches to make information accessible; 2) messaging that will not be interpreted as blaming or shaming; 3) messaging from individuals who engender trust; 4) screening efforts that reach individuals where they are; 5) ways to address practical barriers for screening and treatment, such as cost and transportation; and 6) ways to increase knowledge about insurance coverage for screening and treatment. We also found emergent themes across race, ethnicity, rural/urban residence, sexual orientation/gender identity, and age. Participants pointed to a need to promote positive, culturally sensitive communication between patients and providers and to create safe care spaces, which consider ways cultural and gender norms affect cancer care, to fight stigma and improve health equity. CONCLUSIONS The findings will inform future research and cancer control efforts to address KY's high cancer incidence and mortality rates. Virtual focus groups can be a valuable component of multi-method CNAs that cover a large geographic area and/or with diverse populations to capture community perceptions of cancer-related needs and solutions. Focusing on the cancer care continuum domains, social determinants of health, and unique needs of specific groups provides useful data for CNAs.


Citations (7)


... incidence rates indicate a continuation of prepandemic trends without an obvious recovery of deficient cases from 2020 except for breast cancer. 1,36 Overall cancer incidence in men spiked during the early 1990s because of a surge in the detection of asymptomatic prostate cancer as a result of rapid, widespread uptake of prostate-specific antigen (PSA) testing. 37 Ureter & other urinary organs 4620 2830 1790 1210 650 560 Eye & orbit 3140 1620 1520 490 270 220 Brain & other nervous system 24,820 14,040 10,780 18,330 10,170 8160 Endocrine system 52,140 16,450 35,690 3440 1680 1760 Thyroid 44,020 12,670 31,350 2290 1090 1200 Other endocrine 8120 3780 4340 1150 590 560 Lymphoma 89,070 Alabama 30,030 4960 2630 860 4050 1470 980 5440 1240 230 920 Alaska 3670 550 350 110 430 90 150 710 170 -a 110 Arizona 42,560 6950 3220 1440 4250 3790 1700 5380 2090 270 1450 Arkansas 19,700 2690 1560 590 2660 970 690 2930 780 150 480 California 199,980 32,860 16,050 6000 16,330 11,140 8280 29,600 7220 1490 7480 Colorado 29,020 5250 2130 1030 2520 2060 1210 4400 1220 190 910 Connecticut 23,920 3790 1630 770 2740 780 990 3570 1150 110 positive magnetic resonance imaging (MRI) results. ...

Reference:

Cancer statistics, 2025
COVID-19 and Rates of Cancer Diagnosis in the US
  • Citing Article
  • September 2024

JAMA Network Open

... p < 0.0001), respectively) [14]. Moreover, a recently published cross-sectional study highlighted that age (>65 years old) and socioeconomic status were negative determinants for access to PBT, further underscoring the multifactorial nature of these findings [41]. Notably, not all of these issues can be adequately addressed by multivariable analyses in retrospective studies, and therefore, it still appears that race has a strong independent impact on PBT utilization, potentially related to intrinsic biases and concerns. ...

Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment
  • Citing Article
  • May 2024

JAMA Network Open

... Indeed, the alcohol-smoking patient, in his 6th decade of age with a low socio-economic lifestyle, is considered to be the most frequent patient profile of SCC in the upper aerodigestive tract, and more specifically the oral SCC [1]. However, recently, two other population profiles are emerging for the oral SCC, with an increasing trend in elderly women, possibly linked with denture trauma and toxic exposure [3] and a tendency of increasing tongue cancers in young white women [4,5]. While human papillomavirus (HPV) infection was associated with the increasing incidence of oropharyngeal cancers in nonsmoker young patients, no evident association with oral and tongue cancer in young women has been found. ...

Trends in Oral Tongue Cancer Incidence in the US
  • Citing Article
  • April 2024

JAMA Otolaryngology - Head and Neck Surgery

... The trends may reflect the shift to online forms of recruitment during the COVID-19 pandemic or patients potentially spending more time online. It may also reflect the consequences of delayed screening due to hospital closures, which may have resulted in more severe cases (Burus et al., 2024). ...

Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic
  • Citing Article
  • February 2024

... Hysterectomy information was obtained from the Behavioral Risk Factor Surveillance System (BRFSS) during the study period. Hysterectomy-corrected incidence and mortality rates were estimated following methods employed in similar studies [5,6]. ...

County-Level Trends in Cervical Cancer Incidence, Stage at Diagnosis, and Mortality in Kentucky

JAMA Network Open

... This most significant latent factor influences all cancers and, geographically, it shows a stark contrast between the Mississippi and Ohio River valleys and the rest of the country. The notably higher cancer incidence rates observed in these regions are particularly evident for several cancers including lung cancer [63,64], colon and rectum cancer [65,66], prostate cancer [67], and liver cancer [68]. The long-standing elevated incidence of several cancers in this region has been attributed to factors such as poverty, limited access to healthcare services, higher smoking rates, poor drinking water quality, and industrial/occupational exposures [63,64,69]. ...

Lung and Colorectal Cancer Disparities in Appalachian Kentucky: Spatial Analysis on the Influence of Education and Literacy

... Recent advancements in the diagnostic criteria of CMML have increasingly recognized the importance of molecular features in determining the prognosis of affected patients [1]. CMML is notably challenging due to its varied clinical presentations and outcomes, which are profoundly influenced by genetic abnormalities and the demographic characteristics of the patient population [1,2]. ...

Cancer disparities in Appalachian Kentucky
  • Citing Article
  • April 2023

The Journal of Rural Health